All In MedTech

Device Trial Radar · NCT01970007

VIVO Clinical Study

Evaluation of the Zilver® Vena™ Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction

Last checked: Nov 20, 2026Latest source record: Apr 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

243

Actual

Start

Dec 13, 2013

Primary completion

Nov 20, 2017

Study completion Nov 20, 2019

Sponsor

Lead sponsor
Cook Research IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Oct 25, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the VIVO Clinical Study is to evaluate the safety and effectiveness of the Zilver® Vena™ Venous Stent in the treatment of symptomatic iliofemoral venous outflow obstruction.

Conditions

  • Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein

Interventions

  • Zilver Vena Venous Self-Expanding StentDevice

    stenting

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With 30-day Freedom From Major Adverse EventsTime frame: 30 days
  2. The Rate of Participants With Primary Quantitative Patency at 12 MonthsTime frame: 12 months

Locations

30 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama Birmingham Hospital

    Birmingham, Alabama

  • Arrowhead Hospital

    Glendale, Arizona

  • Littleton Adventist Hospital

    Littleton, Colorado

27 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.